Covid-19: why vaccine mistrust is growing

A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Film supported by Mishcon de Reya. Now & Next is a series from The Economist Films: films.economist.com/nowandnext/
Further content:
Find The Economist’s most recent coverage of covid-19 here: econ.st/3iwmMMH
Sign up to The Economist’s daily newsletter to keep up to date with our latest covid-19 analysis: econ.st/2Ckne0X
The immense promise of the new covid-19 vaccine, and the challenges still to come: econ.st/36EgZAd
Why an effective covid-19 vaccine is a turning point in the pandemic: econ.st/3kJfJRr
Read more about Pfizer’s and BioNTech’s vaccine: econ.st/3pyBvem
A second, better, vaccine against covid-19 arrives-read about Moderna’s vaccine: econ.st/3kEfOpE
Rich countries have grabbed half of projected covid-19 vaccine supply: econ.st/3nveNSm
Daily chart: One in three people want preferential access to a covid-19 vaccine: econ.st/2IyoYah
How pandemic fears are boosting demand for trustworthy news: econ.st/2UzCMU7
Super fast tests for covid-19 are coming: econ.st/32S1Ie5
How the quest for a vaccine could restore faith in big pharma: econ.st/32RSRJn